Learn More
Medchemexpress LLC Palbociclib monohydrochloride | 827022-32-2 | 99.98% | C24H30ClN7O2 | 2 G

Supplier: Medchemexpress LLC HY50767A2G
Palbociclib monohydrochloride (PD 0332991) is an orally active, selective inhibitor of CDK4 and CDK6. It demonstrates potent anti-proliferative activity and induces cell cycle arrest in cancer cells. This compound is utilized in research for HR-positive and HER2-negative breast cancer, as well as hepatocellular carcinoma.
- Orally active, selective inhibitor of CDK4 and CDK6.
- Demonstrates potent anti-proliferative activity.
- Induces cell cycle arrest in cancer cells.
- Utilized in research for HR-positive and HER2-negative breast cancer.
- Used in research for hepatocellular carcinoma.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.